FI942938A0 - Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan - Google Patents

Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan

Info

Publication number
FI942938A0
FI942938A0 FI942938A FI942938A FI942938A0 FI 942938 A0 FI942938 A0 FI 942938A0 FI 942938 A FI942938 A FI 942938A FI 942938 A FI942938 A FI 942938A FI 942938 A0 FI942938 A0 FI 942938A0
Authority
FI
Finland
Prior art keywords
hydrolysates
protection
pharmaceutical compositions
soy protein
bioactive peptides
Prior art date
Application number
FI942938A
Other languages
English (en)
Swedish (sv)
Other versions
FI942938A (fi
Inventor
Gordon L Amidon
Glen D Leesman
Patrick J Sinko
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI942938A publication Critical patent/FI942938A/fi
Publication of FI942938A0 publication Critical patent/FI942938A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI942938A 1991-12-18 1994-06-17 Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan FI942938A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81059391A 1991-12-18 1991-12-18
PCT/US1992/009336 WO1993011799A1 (en) 1991-12-18 1992-11-09 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation

Publications (2)

Publication Number Publication Date
FI942938A FI942938A (fi) 1994-06-17
FI942938A0 true FI942938A0 (fi) 1994-06-17

Family

ID=25204183

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942938A FI942938A0 (fi) 1991-12-18 1994-06-17 Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan

Country Status (12)

Country Link
EP (1) EP0617626A1 (fi)
JP (1) JPH06510796A (fi)
AU (1) AU3058392A (fi)
CA (1) CA2125400A1 (fi)
FI (1) FI942938A0 (fi)
HU (1) HUT69785A (fi)
IL (1) IL104048A0 (fi)
MX (1) MX9207407A (fi)
NO (1) NO942323D0 (fi)
PT (1) PT101135A (fi)
WO (1) WO1993011799A1 (fi)
ZA (1) ZA929761B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007472A1 (en) * 1992-10-02 1994-04-14 Pfizer Inc. Pharmaceutical compositions containing nonionic surfactants
WO1995006463A1 (en) * 1993-09-01 1995-03-09 Pfizer Inc. Pharmaceutical compositions containing anionic surfactants
US6852690B1 (en) 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
DE19530865A1 (de) * 1995-08-22 1997-02-27 Michael Dr Med Nauck Wirkstoff sowie Mittel zur parenteralen Ernährung
CN100366295C (zh) * 2000-01-27 2008-02-06 佩罗斯美国公司 肠递送用组合物
GB0015921D0 (en) * 2000-06-30 2000-08-23 Nat Biolog Standards Board Improvements in or relating to stabilisation of substances
CL2008001640A1 (es) * 2007-06-08 2008-11-07 Bergen Teknologioverforing As Uso de hidroxiprolina para preparar una composicion de alemento destinada a promover el crecimiento de un animal, como peces, aves y mamiferos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4537769A (en) * 1982-04-06 1985-08-27 American Cyanamid Company Stabilization of influenza virus vaccine
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4774089A (en) * 1985-06-14 1988-09-27 Albion International, Inc. Stimulation of gonadotropic hormones with mineral mixtures containing amino acid chelates
MY103189A (en) * 1986-10-31 1993-05-29 Pfizer Nor-statine and nor-cyclostatine polypeptides
EP0327756B1 (en) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
IL90244A (en) * 1988-05-11 1993-05-13 Du Pont Merck Pharma Peptide-drug compositions, for buccal and nasal administration, containing :-aminoboronic acid derivatives
DD273980B5 (de) * 1988-07-12 1994-04-14 Berlin Chemie Ag Verfahren zur Herstellung von Insulin-Pr{paraten zur rektalen Anwendung
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere

Also Published As

Publication number Publication date
FI942938A (fi) 1994-06-17
PT101135A (pt) 1994-03-31
AU3058392A (en) 1993-07-19
WO1993011799A1 (en) 1993-06-24
NO942323L (no) 1994-06-17
HUT69785A (en) 1995-09-28
HU9401824D0 (en) 1994-09-28
JPH06510796A (ja) 1994-12-01
IL104048A0 (en) 1993-05-13
CA2125400A1 (en) 1993-06-24
EP0617626A1 (en) 1994-10-05
NO942323D0 (no) 1994-06-17
ZA929761B (en) 1994-06-17
MX9207407A (es) 1993-06-01

Similar Documents

Publication Publication Date Title
DE69118535D1 (de) Osteo-induktive pharmazeutische formulierungen
HUP0002942A3 (en) Peptides having serine protease inhibiting effect pharmaceutical compositions comprising thereof and their use
IL134732A0 (en) Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
HUP0100669A3 (en) Peptide derivatives as serine protease inhibitors, their use and pharmaceutical compositions comprising thereof
DE69900746D1 (de) Gesteuerte verabreichung von peptiden oder proteinen
TR199501669A1 (tr) Peptid ve proteinlerin aerosol formülasyonlari.
DE69532996D1 (de) Peptidanaloge des menschlichen basischen myelinproteins
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
IL109867A0 (en) alpha-heteroaryloxymethyl ketones as interleukin -1beta protease inhibitors and pharmaceutical compositions containing them
DK0833649T4 (da) Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
HUP0100149A3 (en) Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use
SE0002202D0 (sv) New peptides
MX9708727A (es) Nuevas variantes de la apolipoproteina a-i.
ATE230926T1 (de) Synergistische mischungen von ausgewählten aminosäuren
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
DE69520475D1 (de) Pharmaceutische Zusammensetzung von biologisch aktiven Peptiden oder Proteinen
FI942938A (fi) Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan
IL133176A0 (en) Pharmaceutical compositions of peptides having low solubility in physiological medium
EE200000694A (et) Inimese rekombinantse iterferooni beeta-1a (IFN-ß-1a) formulatsioon
IT1277338B1 (it) Composizioni farmaceutiche di ciclosporina o altre sostanze peptidiche
BR9507063A (pt) Peptídeo derivado de substituição de peptídeo e composição farmacêuticas
ATA114093A (de) Markierte alpha aminosäuren
ITMI930311A0 (it) Composizioni farmeceutiche di derivati amminoacidi

Legal Events

Date Code Title Description
FD Application lapsed